1. Home
  2. GPCR vs VECO Comparison

GPCR vs VECO Comparison

Compare GPCR & VECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • VECO
  • Stock Information
  • Founded
  • GPCR 2016
  • VECO 1945
  • Country
  • GPCR United States
  • VECO United States
  • Employees
  • GPCR N/A
  • VECO N/A
  • Industry
  • GPCR
  • VECO Industrial Machinery/Components
  • Sector
  • GPCR
  • VECO Technology
  • Exchange
  • GPCR Nasdaq
  • VECO Nasdaq
  • Market Cap
  • GPCR 1.8B
  • VECO 1.9B
  • IPO Year
  • GPCR 2023
  • VECO 1994
  • Fundamental
  • Price
  • GPCR $27.03
  • VECO $29.78
  • Analyst Decision
  • GPCR Buy
  • VECO Buy
  • Analyst Count
  • GPCR 6
  • VECO 7
  • Target Price
  • GPCR $85.67
  • VECO $42.14
  • AVG Volume (30 Days)
  • GPCR 797.2K
  • VECO 547.0K
  • Earning Date
  • GPCR 11-13-2024
  • VECO 11-06-2024
  • Dividend Yield
  • GPCR N/A
  • VECO N/A
  • EPS Growth
  • GPCR N/A
  • VECO N/A
  • EPS
  • GPCR N/A
  • VECO 1.35
  • Revenue
  • GPCR N/A
  • VECO $709,094,000.00
  • Revenue This Year
  • GPCR N/A
  • VECO $8.83
  • Revenue Next Year
  • GPCR N/A
  • VECO $2.69
  • P/E Ratio
  • GPCR N/A
  • VECO $20.70
  • Revenue Growth
  • GPCR N/A
  • VECO 9.71
  • 52 Week Low
  • GPCR $29.48
  • VECO $25.52
  • 52 Week High
  • GPCR $62.74
  • VECO $49.25
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 35.94
  • VECO 52.46
  • Support Level
  • GPCR $30.81
  • VECO $27.37
  • Resistance Level
  • GPCR $36.42
  • VECO $29.11
  • Average True Range (ATR)
  • GPCR 2.10
  • VECO 0.94
  • MACD
  • GPCR -0.15
  • VECO 0.12
  • Stochastic Oscillator
  • GPCR 25.07
  • VECO 52.40

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.

Share on Social Networks: